NL-OMON26322尚未招募不适用
Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 52
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Type 2 diabetes
- •eGFR > 45ml/min/1.73m2
排除标准
- •Pregnant women and women of child-bearing potential who are not using
- •reliable contraception
研究者
相似试验
进行中（未招募）
1 期
A rotation study of different albuminuria lowering drug classes to study individual drug response in diabetic and non diabetic Chronic Kideny DiseaseEUCTR2017-004641-25-ESniversity Medical Center Groningen46
进行中（未招募）
1 期
A rotation study of different albuminuria lowering drug classes to study individual drug response in diabetesType 2 diabetes with albuminuriaEUCTR2015-005113-73-NLniversity Medical Center Groningen52
已完成
4 期
Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-1)Albuminuria in patients with diabetes10029149NL-OMON43438niversitair Medisch Centrum Groningen17
进行中（未招募）
1 期
A rotation study of different albuminuria lowering drug classes to study individual drug response in diabetesType 2 diabetes and albuminuriaMedDRA version: 20.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2017-001977-18-DKniversity Medical Center Groningen
进行中（未招募）
1 期
A rotation study of different albuminuria lowering drug classes to study individual drug response in diabetic and non diabetic CKDMedDRA version: 21.1Level: LLTClassification code 10009119Term: Chronic renal failureSystem Organ Class: 100000004857Chronic Kidney DiseaseEUCTR2017-004641-25-ITIVERSITY MEDICAL CENTER GRONINGE46